What does PHARMACIE ROUARD do?

PHARMACIE ROUARD is a pharmacy in Brussel. Public Limited, started on 30 March 1984, 1 establishment.

What is the address of PHARMACIE ROUARD?

The registered office of PHARMACIE ROUARD is located at Maurice Lemonnierlaan 70, 1000 Brussel.

Is PHARMACIE ROUARD still active?

Yes. According to the CBE (15 November 2026) PHARMACIE ROUARD is active, legal situation “Normale toestand”, started on 30 March 1984.

Is PHARMACIE ROUARD registered on Peppol?

Yes, PHARMACIE ROUARD is registered on the Peppol network with ID 0208:0425723892.

What is the enterprise number of PHARMACIE ROUARD?

The enterprise number of PHARMACIE ROUARD is BE0425723892.

When was PHARMACIE ROUARD founded?

PHARMACIE ROUARD was founded on 30 March 1984.

Is PHARMACIE ROUARD a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 March 1984; 5 annual accounts filed, latest fiscal year 2025.

How much profit did PHARMACIE ROUARD make in 2025?

PHARMACIE ROUARD posted a profit after taxes of € 121,632 in financial year 2025.

What is the revenue of PHARMACIE ROUARD?

As a small company, PHARMACIE ROUARD is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 482,691.

How much does an employee at PHARMACIE ROUARD earn?

The average wage cost per full-time employee at PHARMACIE ROUARD was € 36,700 in 2025: staff costs of € 300,678 for 8.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE ROUARD have?

According to the 2025 annual accounts, PHARMACIE ROUARD has 8.2 full-time equivalents (FTE).

PHARMACIE ROUARD (Public Limited) - Brussel

Dossier PHARMACIE ROUARD, printed on 15 November 2026 from databakkes.be/en/0425723892/pharmacie-rouard. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE ROUARD from Brussel, company number BE0425723892, closed financial year 2025 with a result of € 121,632 after tax. For that financial year PHARMACIE ROUARD recorded a gross margin of € 482,691 and equity of € 799,118. Compared with financial year 2024, the result moved from € 117,253 to € 121,632. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What it is worth Healthy

€ 799,118

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 121,632

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 795,968

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 209,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

8.2

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 300,678

▲ 2% vs 2024

€ 36,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,289

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 90,387

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 77,900

▼ 15% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 379,910 Gross margin 2022: € 379,910 First fiscal year in the series	€ 419,078 Gross margin 2023: € 419,078 ▲ 10% vs 2022 (€ 379,910) Favourable step	€ 470,289 Gross margin 2024: € 470,289 ▲ 12% vs 2023 (€ 419,078) Favourable step	€ 482,691 Gross margin 2025: € 482,691 ▲ 3% vs 2024 (€ 470,289) Favourable step	▲ 3%
Profit after taxes	€ 53,922 Profit after taxes 2022: € 53,922 First fiscal year in the series	€ 75,070 Profit after taxes 2023: € 75,070 ▲ 39% vs 2022 (€ 53,922) Favourable step	€ 117,253 Profit after taxes 2024: € 117,253 ▲ 56% vs 2023 (€ 75,070) Favourable step	€ 121,632 Profit after taxes 2025: € 121,632 ▲ 4% vs 2024 (€ 117,253) Favourable step	▲ 4%
Equity	€ 1,019,164 Equity 2022: € 1,019,164 First fiscal year in the series	€ 969,233 Equity 2023: € 969,233 ▼ 5% vs 2022 (€ 1,019,164) Unfavourable step	€ 886,486 Equity 2024: € 886,486 ▼ 9% vs 2023 (€ 969,233) Unfavourable step	€ 799,118 Equity 2025: € 799,118 ▼ 10% vs 2024 (€ 886,486) Unfavourable step	▼ 10%
Total debts	€ 313,110 Total debts 2022: € 313,110 First fiscal year in the series	€ 337,849 Total debts 2023: € 337,849 ▲ 8% vs 2022 (€ 313,110) Unfavourable step	€ 380,077 Total debts 2024: € 380,077 ▲ 12% vs 2023 (€ 337,849) Unfavourable step	€ 405,887 Total debts 2025: € 405,887 ▲ 7% vs 2024 (€ 380,077) Unfavourable step	▲ 7%
Cash	€ 950,826 Cash 2022: € 950,826 First fiscal year in the series	€ 948,980 Cash 2023: € 948,980 Unchanged (€ 950,826) Unfavourable step	€ 872,429 Cash 2024: € 872,429 ▼ 8% vs 2023 (€ 948,980) Unfavourable step	€ 795,968 Cash 2025: € 795,968 ▼ 9% vs 2024 (€ 872,429) Unfavourable step	▼ 9%
Retained profit	€ 944,789 Retained profit 2022: € 944,789 First fiscal year in the series	€ 894,858 Retained profit 2023: € 894,858 ▼ 5% vs 2022 (€ 944,789) Unfavourable step	€ 812,111 Retained profit 2024: € 812,111 ▼ 9% vs 2023 (€ 894,858) Unfavourable step	€ 724,743 Retained profit 2025: € 724,743 ▼ 11% vs 2024 (€ 812,111) Unfavourable step	▼ 11%
Dividend	€ 110,000 Dividend 2022: € 110,000 First fiscal year in the series	€ 125,000 Dividend 2023: € 125,000 ▲ 14% vs 2022 (€ 110,000) Unchanged	€ 200,000 Dividend 2024: € 200,000 ▲ 60% vs 2023 (€ 125,000) Unchanged	€ 209,000 Dividend 2025: € 209,000 ▲ 5% vs 2024 (€ 200,000) Unchanged	▲ 5%
Balance sheet total	€ 1,332,274 Balance sheet total 2022: € 1,332,274 First fiscal year in the series	€ 1,307,083 Balance sheet total 2023: € 1,307,083 ▼ 2% vs 2022 (€ 1,332,274) Unchanged	€ 1,266,563 Balance sheet total 2024: € 1,266,563 ▼ 3% vs 2023 (€ 1,307,083) Unchanged	€ 1,205,004 Balance sheet total 2025: € 1,205,004 ▼ 5% vs 2024 (€ 1,266,563) Unchanged	▼ 5%
Employees (FTE)	8 Employees (FTE) 2022: 8 First fiscal year in the series	7.9 Employees (FTE) 2023: 7.9 ▼ 0.1 vs 2022 (8) Unchanged	8.1 Employees (FTE) 2024: 8.1 ▲ 0.2 vs 2023 (7.9) Unchanged	8.2 Employees (FTE) 2025: 8.2 ▲ 0.1 vs 2024 (8.1) Unchanged	▲ 0.1

By gross margin, PHARMACIE ROUARD ranks 8th of 50 companies with main activity “Detailhandel in farmaceutische producten” in Brussel that publish figures (fiscal year 2025).

Key figures of PHARMACIE ROUARD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about PHARMACIE ROUARD the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to PHARMACIE ROUARD?

What happened at PHARMACIE ROUARD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 17, 2026 New annual accounts for financial year 2025: profit of € 121,632 (▲ 4% vs 2024). Source: NBB ↗
Apr 5, 1984 New establishment in Brussel. KBO
Mar 30, 1984 Start of the company according to the CBE. KBO

In short

From € 53,922 profit in 2022 to € 121,632 profit in 2025.

Paid € 158,908 in corporate taxes since 2022.

Best year ever: 2025, with € 121,632 profit.

On average € 58,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Maurice Lemonnierlaan 70

1000 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Brussel

Same main activity (Detailhandel in farmaceutische producten), 57 active companies in Brussel, largest first.

VERTEX PHARMACEUTICALS (BELGIUM)

€ 88.9 million revenue · 2025

DANSAERT

€ 2.1 million gross margin · 2025

Les Pharmacies de Gare

€ 1.5 million gross margin · 2025

INLEC

€ 771,406 gross margin · 2025

PHARMACIE VLEURGAT

€ 685,436 gross margin · 2025

PharmaOPS.BXL

€ 596,330 gross margin · 2024

All companies with this activity → Largest companies in Brussel →

Details

Company number

0425.723.892

VAT number

BE 0425.723.892

Registered office

Maurice Lemonnierlaan 70, 1000 Brussel

Names & denominations

PHARMACIE ROUARD

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

30 March 1984

Peppol

Active · Active since 17 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗